Clinical Cancer Research Holland2 Stand Up to Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by David, L.
Right arrow Articles by Sobrinho-Simões, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by David, L.
Right arrow Articles by Sobrinho-Simões, M.
Clinical Cancer Research Vol. 6, 4461-4462, November 2000
© 2000 American Association for Cancer Research


Letters to the Editor

Correspondence re: A. E. Biemer-Huttmann et al., Mucin Core Protein Expression in Colorectal Cancers with High Levels of Microsatellite Instability Indicates a Novel Pathway of Morphogenesis. Clin. Cancer Res., 6: 1909–1916, 2000.

Leonor David, Filipe Silva, Raquel Seruca, Mafalda Pinto, Celso Reis and Manuel Sobrinho-Simões

IPATIMUP and Medical Faculty of Porto, Rua Dr. Roberto Frias s/n, 4200 Porto, Portugal

ABSTRACT

In a recent study, Biemer-Huttmann et al. (1) reported that the expression of both MUC2 and MUC5AC mucins is significantly associated with sporadic colorectal carcinomas with MSI-H.1 Because the coexpression of both MUC2 and MUC5AC was observed in 68% of a series of 22 MSI-H cancers and this mucin expression pattern is identical to that observed in serrated polyps of the colorectum (2) , the authors hypothesize that serrated polyps may represent precursors of MSI-H cancers (1) .

The data reported by Biemer-Huttmann et al. (1) are in accordance with our own results on sporadic gastric carcinomas that show a significantly higher frequency of MUC5AC expression in carcinomas with the MSI-H phenotype (Table 1)Citation . In our series, 56.8% of the cases expressing MUC5AC are of the MSI-H phenotype, whereas only 22.2% of the cases with no expression of MUC5AC display the MSI-H phenotype (Table 1)Citation . A similar association was observed between MUC5AC expression and the presence of instability for tetranucleotide STR markers (Table 2)Citation . No relationship between MUC2 expression and the MSI-H phenotype or instability for tetranucleotide STR markers was observed in our series of gastric carcinoma (Tables 1Citation and 2)Citation .


View this table:
[in this window]
[in a new window]

 
Table 1 Relationship between expression of MUC2 and MUC5AC mucins and microsatellite instability in gastric carcinoma

 

View this table:
[in this window]
[in a new window]

 
Table 2 Relationship between expression of MUC2 and MUC5AC mucins and instability for tetranucleotide STR markers in gastric carcinoma

 
In previous studies, our group has shown that MSI is associated with gastric carcinomas of the intestinal/atypical subtypes (3) . At variance with this, expression of MUC5AC was predominantly observed in diffuse gastric carcinomas (4) , and MUC2 expression was predominantly observed in mucinous gastric carcinomas (5) . The results we have obtained recently identify a subgroup of carcinomas that shows high levels of instability for different markers (3 , 6) and maintains a gastric type differentiation with MUC5AC expression.

Together with the results of Biemer-Huttmann et al. (1) on colorectal cancer, our data on gastric cancer suggest that there is a consistent parallel between genetic instability and MUC5AC expression. This is particularly interesting in colorectal tumours because MUC5AC is not expressed in the normal colon mucosa. Further studies should be undertaken to clarify the mechanisms underlying the widespread association of MUC5AC and MSI in tumors of the digestive tract.

FOOTNOTES

1 The abbreviation used is: MSI-H, high level(s) of microsatellite instability. Back

Received 7/27/00; accepted 9/12/00.

REFERENCES

  1. Biemer-Huttmann A. E., Walsh M. D., McGuckin M. A., Simms L. A., Young J., Leggett B. A., Jass J. R. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin. Cancer Res., 6: 1909-1916, 2000.[Abstract/Free Full Text]
  2. Jass J. R. Serrated adenoma and colorectal cancer. J. Pathol., 187: 499-502, 1999.[CrossRef][Medline]
  3. Dos Santos, N. R., Seruca, R., Constância, M., Seixas, M., and Sobrinho-Simões, M. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology, 110: 38–44, 1996.
  4. Reis C. A., David L., Nielsen P., Clausen H., Mirgorodskaya K., Roepstorff P., Sobrinho-Simões M. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int. J. Cancer, 74: 112-121, 1997.[CrossRef][Medline]
  5. Reis C. A., David L., Carvalho F., Mandel U., de Bolós C., Mirgorodskaya K., Clausen H., Sobrinho-Simões M. Immunohistochemical study of the expression of MUC6 mucin and coexpression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J. Histochem. Cytochem., 48: 377-388, 2000.[Abstract/Free Full Text]
  6. Silva F., Gusmão L., Alves C., Seruca R., David L., Amorim A. Tetra- and pentanucleotide short tandem repeat instability in gastric cancer. Electrophoresis, 18: 1633-1636, 1997.[Medline]



This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
N. Kohya, K. Miyazaki, S. Matsukura, H. Yakushiji, Y. Kitajima, K. Kitahara, M. Fukuhara, Y. Nakabeppu, and M. Sekiguchi
Deficient Expression of O6-Methylguanine-DNA Methyltransferase Combined With Mismatch-Repair Proteins hMLH1 and hMSH2 Is Related to Poor Prognosis in Human Biliary Tract Carcinoma
Ann. Surg. Oncol., May 1, 2002; 9(4): 371 - 379.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by David, L.
Right arrow Articles by Sobrinho-Simões, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by David, L.
Right arrow Articles by Sobrinho-Simões, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online